Background Pain during pregnancy is common, and its management is complex. Certain
analgesics may increase the risk for adverse fetal and pregnancy outcomes, while poorly …

Background In 2005, the FDA cautioned that exposure to paroxetine, a selective serotonin
reuptake inhibitor (SSRI), during the first trimester of pregnancy may increase the risk of …

In 2004 the American Society of Echocardiography (ASE) guidelines and standards for the
performance of fetal echocardiography were published. 1 The writing group, commissioned …

Psychiatric conditions (including substance misuse disorders) are serious, potentially life
threatening illnesses that can be successfully treated by psychotropic drugs, even during …

Background There is a marked increase in the use of selective serotonin reuptake inhibitors
and serotonin norepinephrine reuptake inhibitors in the last decade. Many newborns are …

Abstract Purpose of Review To provide an updated summary and appraisal of work from
2019 to 2022 examining risks of selective serotonin reuptake inhibitor (SSRI) use in …

Perinatal depression is a serious psychiatric illness that can have severe and deleterious
effects on the mother, the exposed infant, and the family unit. By definition, perinatal …

Background The prescription of antidepressant drugs during pregnancy has been steadily
increasing for several decades. Meta-analyses (MAs), which increase the statistical power …

Major depressive disorder is common among women in child‐bearing age, and medical
treatment is subject to substantial discussions and controversies. For Selective Serotonin …

Antepartum depression has been associated with low maternal weight gain, 1 increased
rates of preterm birth, 1, 2 low birth weight, 1 increased rates of cigarette, alcohol, and other …